Skip to the page

Data / Drug companies / Venlafaxine hydrochloride

Venlafaxine hydrochloride: 48 companies and 213 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Venlafaxine hydrochloride is listed in the FDA National Drug Code Directory by 48 companies, with 213 products in commercial distribution. 208 of the products (97.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, extended release; tablet; tablet, extended release, and the newest product started marketing on November 2, 2026.

The request: Get every company that lists venlafaxine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
48
Products
213
Generic (ANDA) products
208 (97.7%)
Application numbers
22
Routes
Oral
Brand names
Venlafaxine, Venlafaxine, Effexor XR
openFDA record search
api.fda.gov

Companies that list venlafaxine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions19capsule, extended release; tabletGeneric drugs (ANDA)September 7, 2022
Bryant Ranch Prepack15capsule, extended release; tabletGeneric drugs (ANDA)September 25, 2023
Remedyrepack Inc.13capsule, extended release; tabletGeneric drugs (ANDA)April 24, 2026
Advanced Rx of Tennessee, LLC10capsule, extended release; tablet, extended releaseGeneric drugs (ANDA)April 9, 2026
NuCare Pharmaceuticals,Inc.9capsule, extended releaseGeneric drugs (ANDA)September 25, 2023
Aurobindo Pharma Limited8tablet; capsule, extended releaseGeneric drugs (ANDA)November 23, 2011
Dr. Reddy's Laboratories Limited8tablet; capsule, extended releaseGeneric drugs (ANDA)June 1, 2011
Teva Pharmaceuticals USA, Inc.8tablet; capsule, extended releaseGeneric drugs (ANDA)July 1, 2010
Zydus Lifesciences Limited8tablet; capsule, extended releaseGeneric drugs (ANDA)June 1, 2011
Coupler LLC5capsule, extended release; tabletGeneric drugs (ANDA)November 2, 2026
Preferred Pharmaceuticals Inc.5capsule, extended releaseGeneric drugs (ANDA)February 27, 2025
Rising Pharma Holdings, Inc.5tabletGeneric drugs (ANDA)April 7, 2010
Yaopharma Co., Ltd.5tabletGeneric drugs (ANDA)September 6, 2016
Advagen Pharma Ltd4capsule, extended releaseGeneric drugs (ANDA)March 20, 2020
Sun Pharmaceutical Industries, Inc.4tablet, extended releaseGeneric drugs (ANDA)February 15, 2019
Alembic Pharmaceuticals Inc.3capsule, extended releaseGeneric drugs (ANDA)June 10, 2024
Alembic Pharmaceuticals Limited3capsule, extended releaseGeneric drugs (ANDA)June 10, 2024
American Health Packaging3capsule, extended releaseGeneric drugs (ANDA)June 3, 2014
Annora Pharma Private Limited3capsule, extended releaseGeneric drugs (ANDA)July 8, 2019
Asclemed USA, Inc.3capsule, extended releaseGeneric drugs (ANDA)November 23, 2011
AvKARE3capsule, extended releaseGeneric drugs (ANDA)July 10, 2013
AvPAK3capsule, extended releaseGeneric drugs (ANDA)February 25, 2025
Camber Pharmaceuticals, Inc.3capsule, extended releaseGeneric drugs (ANDA)July 8, 2019
Dr. Reddy's Laboratories Inc.3capsule, extended releaseGeneric drugs (ANDA)September 9, 2024
Epic Pharma, LLC3capsule, extended releaseGeneric drugs (ANDA)September 7, 2022
Granules Pharmaceuticals Inc.3capsule, extended releaseGeneric drugs (ANDA)September 25, 2023
Macleods Pharmaceuticals Limited3capsule, extended releaseGeneric drugs (ANDA)October 6, 2017
Major Pharmaceuticals3capsule, extended releaseGeneric drugs (ANDA)October 8, 2025
Marlex Pharmaceuticals, Inc.3capsule, extended releaseGeneric drugs (ANDA)August 1, 2025
NCS HealthCare of Ky, LLC DBA Vangard Labs3capsule, extended release; tabletGeneric drugs (ANDA)September 25, 2023
Nivagen Pharmaceuticals, Inc.3tablet, extended releaseGeneric drugs (ANDA)September 6, 2019
NorthStar RxLLC3capsule, extended releaseGeneric drugs (ANDA)June 1, 2026
Northwind Health Company, LLC3tablet; capsule, extended releaseGeneric drugs (ANDA)May 2, 2023
Proficient Rx LP3capsule, extended releaseGeneric drugs (ANDA)July 8, 2019
Proficient Rx LP3capsule, extended releaseGeneric drugs (ANDA)July 1, 2010
Puracap Laboratories LLC DBA Blu Pharmaceuticals3capsule, extended releaseGeneric drugs (ANDA)July 28, 2026
Quallent Pharmaceuticals Health LLC3capsule, extended releaseGeneric drugs (ANDA)November 21, 2022
Viatris Specialty LLC3capsule, extended releaseNew drug applications (NDA)October 30, 2024
Zydus Lifesciences Limited3capsule, extended releaseGeneric drugs (ANDA)May 18, 2023
Zydus Pharmaceuticals USA Inc.3capsule, extended releaseGeneric drugs (ANDA)May 18, 2023
Zydus Pharmaceuticals USA Inc.3capsule, extended releaseGeneric drugs (ANDA)June 1, 2011
QPharma, Inc.2capsule, extended releaseGeneric drugs (ANDA)June 1, 2011
Westminster Pharmaceuticals, LLC2tablet, extended releaseGeneric drugs (ANDA)November 18, 2025
Cardinal Health 107, LLC1capsule, extended releaseGeneric drugs (ANDA)March 23, 2026
Chartwell RX, LLC1tabletGeneric drugs (ANDA)December 26, 2019
Proficient Rx LP1capsule, extended releaseGeneric drugs (ANDA)November 23, 2011
St. Mary's Medical Park Pharmacy1capsule, extended releaseGeneric drugs (ANDA)June 1, 2011
Trigen Laboratories, LLC1tablet, extended releaseAuthorized generics (NDA)April 29, 2010

Dosage forms

Dosage formProductsShare
Capsule, extended release15974.6%
Tablet4320.2%
Tablet, extended release115.2%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)20897.7%
New drug applications (NDA)31.4%
Authorized generics (NDA)20.9%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.